Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19–related Acute Respiratory Distress Syndrome: Worth the Effort? - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue American Journal of Respiratory and Critical Care Medicine Année : 2020

Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19–related Acute Respiratory Distress Syndrome: Worth the Effort?

Pierre-Emmanuel Falcoz
  • Fonction : Auteur
  • PersonId : 1118744
Alexandra Monnier
  • Fonction : Auteur
Marc Puyraveau
  • Fonction : Auteur
Stéphanie Perrier
  • Fonction : Auteur
  • PersonId : 1132445
Anne Olland
  • Fonction : Auteur
  • PersonId : 1132446
Francis Schneider
Julie Helms
  • Fonction : Auteur
  • PersonId : 1076641
Ferhat Meziani
  • Fonction : Auteur
  • PersonId : 1076640

Résumé

According to Chinese and Italian reports, 15–42% of patients with coronavirus disease (COVID-19) develop acute respiratory distress syndrome (ARDS), with a 60% mortality rate (1–3). Venovenous extracorporeal membrane oxygenation (VV-ECMO) is therefore considered a rescue therapy to be used in the most severe ARDS, as recommended by the World Health Organization’s interim guidelines for the management of patients with COVID-19 (4). However, without a significant impact on mortality, the benefit of ECMO in ARDS remains controversial (5). Generally, only few data on the use of ECMO in the present pandemic are available (1, 2) with a short follow-up (6, 7). However, accurately selecting patients with COVID-19–related ARDS, who may be good candidates for ECMO support, is important during a pandemic characterized by limited medical resources.

Dates et versions

hal-03640867 , version 1 (13-04-2022)

Identifiants

Citer

Pierre-Emmanuel Falcoz, Alexandra Monnier, Marc Puyraveau, Stéphanie Perrier, Pierre-Olivier Ludes, et al.. Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19–related Acute Respiratory Distress Syndrome: Worth the Effort?. American Journal of Respiratory and Critical Care Medicine, 2020, 202 (3), pp.460-463. ⟨10.1164/rccm.202004-1370LE⟩. ⟨hal-03640867⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More